Work

Correction to “Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis”

Year: 2022

Type: erratum

Source: ACS Chemical Neuroscience

DOI: 10.1021/acschemneuro.2c00459

Authors: M. Ashraf-Uz-Zaman, G. Ji, D. Tidwell, L. Yin, S. Thakolwiboon, J. Pan, R. Junell, Z. Griffin, S. Shahi, D. Barthels, M. S. Sajib, P. C. Trippier, C. M. Mikelis, H. Das, M. Avila, V. Neugebauer, N. A. German

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Prevention and Research Institute of Texas, South Plains Foundation, National Institute of Mental Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G1915163810, G282873053, Novel Class of Chemotherapeutic Agents for Treatment of Metastatic Triple-negative Breast Cancer, Texas Regional Excellence in Cancer Developmental Therapeutics Center at TTUHSC, North Texas Clinical Pharmacology Cancer Core, G5978445615, G7907134400

OpenAlex ID: W4306893509

Cites:

Cited by:

Related to: 10